The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae
- PMID: 9222040
- DOI: 10.1093/jac/39.6.719
The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae
Abstract
The bactericidal activity of levofloxacin was compared with that of four other quinolones and one cephalosporin against four strains of Streptococcus pneumoniae with varying degrees of penicillin G susceptibility. Levofloxacin was found to be the most bactericidal quinolone at its optimum bactericidal concentration, followed by ofloxacin, ciprofloxacin, sparfloxacin and D-ofloxacin, in that order. There was no correlation between quinolone-susceptibility and penicillin-susceptibility with any quinolone tested. To allow a comparison between the bactericidal activity of the quinolones and cefotaxime to be made a bactericidal index was used. Against two penicillin-sensitive pneumococci and a penicillin-intermediate pneumococcus, cefotaxime was the most potent antibacterial agent tested, followed by levofloxacin. However, against the penicillin-resistant pneumococcus, levofloxacin was considerably more potent than cefotaxime. The remaining quinolones tested were inferior to levofloxacin. Levofloxacin has enhanced activity against pneumococci compared with clinically available quinolones. In addition, levofloxacin may be the future quinolone of choice in the treatment of penicillin-resistant pneumococci.
Comment in
-
A reverse-phase, isocratic high-performance liquid chromatography assay for levofloxacin.J Antimicrob Chemother. 1999 Mar;43(3):434-5. doi: 10.1093/jac/43.3.434. J Antimicrob Chemother. 1999. PMID: 10223609 No abstract available.
Similar articles
-
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.Antimicrob Agents Chemother. 1996 Feb;40(2):362-6. doi: 10.1128/AAC.40.2.362. Antimicrob Agents Chemother. 1996. PMID: 8834881 Free PMC article.
-
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.J Antimicrob Chemother. 1999 May;43(5):645-9. doi: 10.1093/jac/43.5.645. J Antimicrob Chemother. 1999. PMID: 10382885
-
In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.J Antimicrob Chemother. 1999 Jun;43 Suppl C:9-14. doi: 10.1093/jac/43.suppl_3.9. J Antimicrob Chemother. 1999. PMID: 10404331
-
Levofloxacin and sparfloxacin: new quinolone antibiotics.Ann Pharmacother. 1998 Mar;32(3):320-36. doi: 10.1345/aph.17178. Ann Pharmacother. 1998. PMID: 9533064 Review.
-
Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.J Chemother. 2004 Apr;16 Suppl 2:3-7. doi: 10.1080/1120009x.2004.11782365. J Chemother. 2004. PMID: 15255554 Review. No abstract available.
Cited by
-
[Role of new fluoroquinolones in respiratory infections in primary care].Aten Primaria. 2000 Apr 30;25(7):512-7. doi: 10.1016/s0212-6567(00)78557-x. Aten Primaria. 2000. PMID: 10917693 Free PMC article. Review. Spanish. No abstract available.
-
Suppression of Reactive Oxygen Species Accumulation Accounts for Paradoxical Bacterial Survival at High Quinolone Concentration.Antimicrob Agents Chemother. 2018 Feb 23;62(3):e01622-17. doi: 10.1128/AAC.01622-17. Print 2018 Mar. Antimicrob Agents Chemother. 2018. PMID: 29229642 Free PMC article.
-
Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections.Curr Infect Dis Rep. 2000 Oct;2(5):399-408. doi: 10.1007/s11908-000-0066-0. Curr Infect Dis Rep. 2000. PMID: 11095884
-
Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials.CMAJ. 2008 Mar 25;178(7):845-54. doi: 10.1503/cmaj.071157. CMAJ. 2008. PMID: 18362380 Free PMC article. Review.
-
Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.Drugs. 1998 Sep;56(3):487-515. doi: 10.2165/00003495-199856030-00013. Drugs. 1998. PMID: 9777318 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources